Literature DB >> 9677545

[Diagnostic imaging of intraocular lesions in the child].

A Balmer1, F Munier, S Uffer.   

Abstract

BACKGROUND: A certain diagnosis, as soon as possible, is indispensable in children with intraocular lesions, the presence of retinoblastoma always being a possibility. PATIENTS: From our casuistic of 418 children since 1970 and from the literature, we currently adopt the following attitude. Where the media are clear, a drawing and fundus photographs are made. Echography is performed in all cases. Ultrasound biomicroscopic examination is carried out in all lesions where involvement of the anterior segment is suspected.
RESULTS: Where echography shows no calcifications, computed tomography (CT) is indicated. CT may also enable a possible lesion extension, particularly to the optic nerve, to be studied.
CONCLUSIONS: Magnetic resonance imaging (RMI) is the procedure of choice for evaluating secondary retinal detachment, massive extension of retinoblastoma and for detecting any early involvement of the pineal gland (pinealoblastoma), or any other associated lesion. In case of unilateral unifocal sporadic retinoblastoma, however, no CT or MRI is performed, except where there is a suspected extension into the optic nerve or the orbit. Echography remains the most economical, rapid and safest means of diagnosis even in difficult cases.

Entities:  

Mesh:

Year:  1998        PMID: 9677545     DOI: 10.1055/s-2008-1034872

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

1.  Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results.

Authors:  Arne-Jörn Lemke; Iris Kazi; Ulrike Mergner; Paul Ivan Foerster; Heinrich Heimann; Nikolaos Bechrakis; Andreas Schüler; Marie-Isabell Senfft von Pilsach; Michael Foerster; Roland Felix; Norbert Hosten
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

2.  High resolution magnetic resonance imaging of retinoblastoma.

Authors:  A O Schueler; N Hosten; N E Bechrakis; A J Lemke; P Foerster; R Felix; M H Foerster; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.